Financial Constraints to Molecular Biomarker Testing

David L. Rimm, MD, PhD; Roy Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. David Rimm and Roy Herbst discuss the challenges of reimbursement by payers and the costs to pathology department of molecular biomarker testing, especially immunohistochemistry and DNA testing.

Related Videos

March 31, 2015

New Targets = Better Standard of Care

Alexander Bastian mentions that looking at more defined populations and leveraging the power of targeted medicine is improving the standard of care.

January 30, 2014

Oncology and the Affordable Care Act

Hear as Dr Agarwala deliberates the impact of the Affordable Care Act on oncology care.